- Home
- CDIO vs MMA Comparison
CDIO vs MMA Comparison
Compare CDIO & MMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- MMA
- Stock Information
- Founded
- CDIO 2017
- MMA 2013
- Country
- CDIO United States
- MMA Australia
- Employees
- CDIO N/A
- MMA N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- MMA
- Sector
- CDIO Health Care
- MMA
- Exchange
- CDIO Nasdaq
- MMA Nasdaq
- Market Cap
- CDIO 19.5M
- MMA 15.9M
- IPO Year
- CDIO N/A
- MMA 2024
- Fundamental
- Price
- CDIO $4.53
- MMA $0.77
- Analyst Decision
- CDIO Buy
- MMA
- Analyst Count
- CDIO 1
- MMA 0
- Target Price
- CDIO $2.00
- MMA N/A
- AVG Volume (30 Days)
- CDIO 68.6K
- MMA 72.8K
- Earning Date
- CDIO 05-23-2025
- MMA 01-21-2025
- Dividend Yield
- CDIO N/A
- MMA N/A
- EPS Growth
- CDIO N/A
- MMA N/A
- EPS
- CDIO N/A
- MMA N/A
- Revenue
- CDIO $34,890.00
- MMA $375,175.00
- Revenue This Year
- CDIO $1,434.82
- MMA N/A
- Revenue Next Year
- CDIO $4,661.91
- MMA N/A
- P/E Ratio
- CDIO N/A
- MMA N/A
- Revenue Growth
- CDIO 104.45
- MMA 45.19
- 52 Week Low
- CDIO $0.19
- MMA $0.60
- 52 Week High
- CDIO $1.77
- MMA $5.00
- Technical
- Relative Strength Index (RSI)
- CDIO 29.92
- MMA N/A
- Support Level
- CDIO $4.50
- MMA N/A
- Resistance Level
- CDIO $14.46
- MMA N/A
- Average True Range (ATR)
- CDIO 1.69
- MMA 0.00
- MACD
- CDIO -0.97
- MMA 0.00
- Stochastic Oscillator
- CDIO 4.66
- MMA 0.00
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
About MMA Alta Global Group Limited
Mixed Martial Arts Group Ltd formerly Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.